Overview
Celebrating its 18th year, the DIA Global QPPV Forum continues to be the only forum designed for QPPVs by QPPVs. This unique platform provides a safe and trustworthy environment for QPPVs to exchange information, get inspired by colleagues, and network with peers that they only meet at this conference. The forum is not just a valuable opportunity to network, but also an educational conference that offers a broad perspective on the field. With a focus on practical cases and solutions, it’s a great place to present challenges and collectively find solutions with your peers.
Participant Testimonials
"Love the general feel of the meeting - friendly, open, honest and all willing to share and learn."
"I heard a lot of valuable input for topics under discussion in my company."
"A great gathering of experts discussing relevant topics."
Featured
Want to learn more about Global Forum for Qualified Persons for Pharmacovigilance (QPPV)? You've come to the right site!
Program Committee
-
Gemma Jimenez Sese Senior Director, Deputy EU QPPV
AstraZeneca, Spain -
Maarten Lagendijk, MSc Deputy EU QPPV
MSD, Netherlands -
Angela Van Der Salm, PhD, MSc Director PV, Managing partner
DADA Consultancy B.V., Netherlands -
Shahinaz Badr Pharmacovigilance Consultant and PVQA Auditor - EMEA
Pharma Quality Europe, United Arab Emirates -
Vicki Edwards, RPh Vice President, Pharmacovigilance Excellence and International QPPV
Abbvie, United Kingdom -
Magnus Ysander, MD EU & UK QPPV & Head Pharmacovigilance Excellence
AstraZeneca, Sweden -
Elspeth McIntosh, MBA, RN Director
Castle Pharmacovigilance Ltd, United Kingdom -
Katarzyna Swiderek, MPharm, RPh Director, Safety Evaluation Risk Management (SERM)
GlaxoSmithKline, Poland -
Claire Longman, MSc Expert Pharmacovigilance Inspector
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom -
Willemijn van der Spuij, MSc Executive Director, WorldWide Patient Safety International, Europe
Switzerland
Have an account?